Select Equity Group’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,050
Closed -$793K 175
2020
Q4
$793K Buy
10,050
+1,239
+14% +$72.7K ﹤0.01% 105
2020
Q3
$387K Buy
8,811
+2,157
+32% +$106K ﹤0.01% 133
2020
Q2
$294K Buy
+6,654
New +$248K ﹤0.01% 133
2020
Q1
Sell
-143,584
Closed -$10.2M 134
2019
Q4
$10.2M Sell
143,584
-260,055
-64% -$18.9M 0.06% 96
2019
Q3
$30.2M Sell
403,639
-30,818
-7% -$2.61M 0.2% 74
2019
Q2
$35M Buy
434,457
+202,974
+88% +$14.3M 0.24% 67
2019
Q1
$15.5M Buy
+231,483
New +$17.5M 0.1% 77
2018
Q1
Sell
-125,062
Closed -$12.9M 100
2017
Q4
$12.9M Sell
125,062
-19,347
-13% -$1.93M 0.1% 79
2017
Q3
$13.6M Buy
+144,409
New +$11.4M 0.1% 76

Other funds holding CMD

Select Equity Group's CMD Position: Q1 2021 in Review

Select Equity Group sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 10,050 shares — an estimated $793K sold.

Select Equity Group first reported a position in CMD in Q3 2017 and held it in 9 quarters. The position peaked at $35M in Q2 2019. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Select Equity Group reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Select Equity Group sold 10,050 Cantel Medical Corporation shares in Q1 2021, an estimated $793K.
  • Select Equity Group first reported a position in Cantel Medical Corporation in Q3 2017 and held it in 9 quarters.
  • Select Equity Group's Cantel Medical Corporation position peaked at $35M in Q2 2019.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Select Equity Group's 13F filing for Q1 2021, filed 17 May 2021.